These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 10829310

  • 1. [What is the value of neoadjuvant therapy in bronchial carcinoma?].
    Digel W, Brethner L, Hasse J.
    Zentralbl Chir; 2000; 125(4):315-8. PubMed ID: 10829310
    [Abstract] [Full Text] [Related]

  • 2. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.
    Machtay M, Lee JH, Stevenson JP, Shrager JB, Algazy KM, Treat J, Kaiser LR.
    J Thorac Cardiovasc Surg; 2004 Jan; 127(1):108-13. PubMed ID: 14752420
    [Abstract] [Full Text] [Related]

  • 3. [Neoadjuvant therapy of stage III non-small cell lung cancer].
    Hara N, Ohta M.
    Kyobu Geka; 1991 Dec; 44(13):1114-20. PubMed ID: 1661792
    [Abstract] [Full Text] [Related]

  • 4. Pneumonectomy is a valuable treatment option after neoadjuvant therapy for stage III non-small-cell lung cancer.
    Weder W, Collaud S, Eberhardt WE, Hillinger S, Welter S, Stahel R, Stamatis G.
    J Thorac Cardiovasc Surg; 2010 Jun; 139(6):1424-30. PubMed ID: 20416887
    [Abstract] [Full Text] [Related]

  • 5. Trimodal therapy for histologically proven N2/3 non-small cell lung cancer: mid-term results and indicators for survival.
    Steger V, Walles T, Kosan B, Walker T, Kyriss T, Veit S, Dippon J, Friedel G.
    Ann Thorac Surg; 2009 Jun; 87(6):1676-83. PubMed ID: 19463576
    [Abstract] [Full Text] [Related]

  • 6. Survival of patients with advanced non-small-cell lung cancer at Ubon Ratchathani Cancer Center, Thailand.
    Srisam-Ang K, Podhipak A, Narksawat K, Supaattagorn P, Tipayamongkholgul M.
    Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):994-1006. PubMed ID: 16295558
    [Abstract] [Full Text] [Related]

  • 7. The incidence of perioperative anastomotic complications after sleeve lobectomy is not increased after neoadjuvant chemoradiotherapy.
    Milman S, Kim AW, Warren WH, Liptay MJ, Miller C, Basu S, Faber LP.
    Ann Thorac Surg; 2009 Sep; 88(3):945-50; discussion 950-1. PubMed ID: 19699925
    [Abstract] [Full Text] [Related]

  • 8. Post-chemotherapy gross tumor volume is predictive of survival in patients with stage III non-small cell lung cancer treated with combined modality therapy.
    Stinchcombe TE, Morris DE, Moore DT, Bechtel JH, Halle JS, Mears A, Deschesne K, Rosenman JG, Socinski MA.
    Lung Cancer; 2006 Apr; 52(1):67-74. PubMed ID: 16499996
    [Abstract] [Full Text] [Related]

  • 9. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.
    Sonett JR, Suntharalingam M, Edelman MJ, Patel AB, Gamliel Z, Doyle A, Hausner P, Krasna M.
    Ann Thorac Surg; 2004 Oct; 78(4):1200-5; discussion 1206. PubMed ID: 15464470
    [Abstract] [Full Text] [Related]

  • 10. [Is preoperative chemotherapy in locally advanced non-small-cell bronchial carcinoma of value?].
    Betticher DC, von Briel C, Gugger M, Cerny T, Ris HB.
    Ther Umsch; 1998 Jul; 55(7):399-401. PubMed ID: 9702102
    [Abstract] [Full Text] [Related]

  • 11. Multimodality therapy for non-small-cell lung cancer.
    Lilenbaum RC, Green MR.
    Oncology (Williston Park); 1994 May; 8(5):25-31; discussion 32, 35-6. PubMed ID: 8025004
    [Abstract] [Full Text] [Related]

  • 12. [Role of chemo(radio)theray prior to surgery for stage IIIa non-small cell lung carcinoma (localized non-resectable tumor)].
    Smit EF, van Mourik JC, Slotman BJ, Postmus PE.
    Ned Tijdschr Geneeskd; 1999 Oct 02; 143(40):1992-6. PubMed ID: 10535055
    [Abstract] [Full Text] [Related]

  • 13. Resected non-small-cell lung cancer stage I/II: indication for adjuvant/neoadjuvant therapy?
    Hoffmann H.
    Lung Cancer; 2004 Aug 02; 45 Suppl 2():S91-7. PubMed ID: 15552788
    [Abstract] [Full Text] [Related]

  • 14. A phase II study of induction chemotherapy followed by concurrent chemoradiotherapy in elderly patients with locally advanced non-small-cell lung cancer.
    Giorgio CG, Pappalardo A, Russo A, Santini D, Di Rosa C, Di Salvo C, Castorina S, Marletta F, Bellissima G, Palermo N, Scuderi C, Bordonaro R.
    Anticancer Drugs; 2007 Jul 02; 18(6):713-9. PubMed ID: 17762402
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Predicting efficacy of neoadjuvant cheomotherapy on resectable stage IIIA non-small cell lung cancer by multi-gene expressions].
    Cheng C, Wu YL, Gu LJ, Chen G, Weng YM, Feng WN, Zhong WZ.
    Ai Zheng; 2005 Jul 02; 24(7):846-9. PubMed ID: 16004813
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Multimodality therapy for stage III non-small-cell lung cancer.
    Farray D, Mirkovic N, Albain KS.
    J Clin Oncol; 2005 May 10; 23(14):3257-69. PubMed ID: 15886313
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.